Cyber-Seminar Series: Accelerating HPV Vaccine Uptake: What is Working and Why

Research to Reality’s Cyber-Seminar Series
Accelerating HPV Vaccine Uptake: What is Working and Why
September 22, 2014, 2:00pm – 3:00pm

Human papillomaviruses (HPV) cause most cases of cervical cancer and large proportions of vaginal, vulvar, anal, penile, and oropharyngeal cancers. HPV vaccines could dramatically reduce the incidence of HPV-associated cancers and other conditions among both females and males, but the uptake of vaccines has fallen short of target levels. The September NCI Research to Reality cyber-seminar will present key goals and high priority research interventions to increase HPV vaccine uptake. We also will highlight promising interventions that through a variety of strategies have created substantive changes in accelerating HPV vaccine uptake.


More information and registration.